Vident Advisory LLC Boosts Holdings in Intuitive Surgical, Inc. $ISRG

Key Points

• Vident Advisory LLC increased its stake in Intuitive Surgical by 44.0%, acquiring an additional 3,948 shares for a total of 12,920 shares valued at approximately $6.4 million.
• Institutional investors now own 83.64% of Intuitive Surgical, with notable increases in holdings from firms such as GAMMA Investing LLC, which raised its stake by 54,010.7% during the first quarter.
• Intuitive Surgical reported a quarterly EPS of $2.19, exceeding estimates by $0.26, and had a revenue increase of 21.4% year-over-year.

Vident Advisory LLC grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 44.0% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 12,920 shares of the medical equipment provider's stock after purchasing an additional 3,948 shares during the quarter. Vident Advisory LLC's holdings in Intuitive Surgical were worth $6,400,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in ISRG. Nuveen LLC purchased a new stake in shares of Intuitive Surgical during the first quarter valued at approximately $1,715,899,000. GAMMA Investing LLC increased its position in Intuitive Surgical by 54,010.7% during the 1st quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock valued at $14,999,630,000 after purchasing an additional 3,022,979 shares during the period. Goldman Sachs Group Inc. lifted its position in shares of Intuitive Surgical by 26.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider's stock worth $1,396,496,000 after purchasing an additional 584,375 shares during the period. Wellington Management Group LLP lifted its position in shares of Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider's stock worth $1,732,975,000 after purchasing an additional 457,080 shares during the period. Finally, Vanguard Group Inc. boosted its stake in shares of Intuitive Surgical by 1.4% during the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider's stock valued at $16,178,258,000 after purchasing an additional 453,335 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Price Performance

NASDAQ ISRG traded down $4.23 during trading hours on Tuesday, hitting $469.07. The company's stock had a trading volume of 2,229,121 shares, compared to its average volume of 1,990,367. The company's 50 day simple moving average is $499.62 and its two-hundred day simple moving average is $516.13. The company has a market cap of $168.15 billion, a P/E ratio of 65.42, a price-to-earnings-growth ratio of 4.96 and a beta of 1.61. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business's quarterly revenue was up 21.4% compared to the same quarter last year. During the same period in the previous year, the company posted $1.78 EPS. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares of the company's stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 44,984 shares of company stock valued at $21,651,231 in the last ninety days. Corporate insiders own 0.70% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on ISRG shares. Wall Street Zen raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. Royal Bank Of Canada reissued an "outperform" rating and issued a $615.00 target price on shares of Intuitive Surgical in a research report on Tuesday, August 19th. BTIG Research raised their price objective on Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reissued a "sell" rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Finally, Evercore ISI raised their price objective on Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research report on Tuesday, July 8th. Thirteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.